PortfoliosLab logo
Tools
Performance Analysis
Risk Analysis
Optimization
Factor Model
See All Tools
Portfolio Analysis
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
Affimed N.V. (AFMD)
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Company Info

ISINNL0010872420
CUSIP001087242
SectorHealthcare
IndustryBiotechnology

Highlights

Market Cap$79.15M
EPS-$8.56
Revenue (TTM)$21.02M
Gross Profit (TTM)$42.87M
EBITDA (TTM)-$113.90M
Year Range$2.24 - $11.10
Target Price$38.21
Short %1.20%
Short Ratio1.54

Share Price Chart


Loading data...

Compare to other instruments

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Affimed N.V.

Performance

Performance Chart

The chart shows the growth of an initial investment of $10,000 in Affimed N.V., comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.


-100.00%-50.00%0.00%50.00%100.00%150.00%NovemberDecember2024FebruaryMarchApril
-90.82%
152.94%
AFMD (Affimed N.V.)
Benchmark (^GSPC)

S&P 500

Returns By Period

Affimed N.V. had a return of -16.32% year-to-date (YTD) and -34.97% in the last 12 months.


PeriodReturnBenchmark
Year-To-Date-16.32%5.29%
1 month15.20%-2.47%
6 months37.89%16.40%
1 year-34.97%20.88%
5 years (annualized)-31.09%11.60%
10 years (annualized)N/A10.43%

Monthly Returns Heatmap


JanFebMarAprMayJunJulAugSepOctNovDec
2024-11.84%9.26%-11.96%
2023-12.15%-17.35%13.92%38.89%

Risk-Adjusted Performance

Risk-Adjusted Performance Rank

The current rank of AFMD is 34, suggesting that the investment has average results relative to the market in terms of risk-adjusted performance. This ranking is determined by the cumulative values of the indicators listed below.

The Risk-Adjusted Performance Rank of AFMD is 3434
Affimed N.V.(AFMD)
The Sharpe Ratio Rank of AFMD is 3131Sharpe Ratio Rank
The Sortino Ratio Rank of AFMD is 3636Sortino Ratio Rank
The Omega Ratio Rank of AFMD is 3636Omega Ratio Rank
The Calmar Ratio Rank of AFMD is 3030Calmar Ratio Rank
The Martin Ratio Rank of AFMD is 3535Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

Risk-Adjusted Performance Indicators

The charts below present risk-adjusted performance metrics for Affimed N.V. (AFMD) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.


AFMD
Sharpe ratio
The chart of Sharpe ratio for AFMD, currently valued at -0.40, compared to the broader market-2.00-1.000.001.002.003.00-0.40
Sortino ratio
The chart of Sortino ratio for AFMD, currently valued at -0.10, compared to the broader market-4.00-2.000.002.004.00-0.10
Omega ratio
The chart of Omega ratio for AFMD, currently valued at 0.99, compared to the broader market0.501.001.500.99
Calmar ratio
The chart of Calmar ratio for AFMD, currently valued at -0.37, compared to the broader market0.001.002.003.004.005.00-0.37
Martin ratio
The chart of Martin ratio for AFMD, currently valued at -0.75, compared to the broader market0.0010.0020.0030.00-0.75
^GSPC
Sharpe ratio
The chart of Sharpe ratio for ^GSPC, currently valued at 1.79, compared to the broader market-2.00-1.000.001.002.003.001.79
Sortino ratio
The chart of Sortino ratio for ^GSPC, currently valued at 2.61, compared to the broader market-4.00-2.000.002.004.002.61
Omega ratio
The chart of Omega ratio for ^GSPC, currently valued at 1.31, compared to the broader market0.501.001.501.31
Calmar ratio
The chart of Calmar ratio for ^GSPC, currently valued at 1.36, compared to the broader market0.001.002.003.004.005.001.36
Martin ratio
The chart of Martin ratio for ^GSPC, currently valued at 7.21, compared to the broader market0.0010.0020.0030.007.21

Sharpe Ratio

The current Affimed N.V. Sharpe ratio is -0.40. A negative Sharpe ratio means that the risk-free rate is higher than the portfolio's return. This value does not convey any meaningful information.


Rolling 12-month Sharpe Ratio-1.000.001.002.003.00NovemberDecember2024FebruaryMarchApril
-0.40
1.79
AFMD (Affimed N.V.)
Benchmark (^GSPC)

Dividends

Dividend History


Affimed N.V. doesn't pay dividends

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.


-100.00%-80.00%-60.00%-40.00%-20.00%0.00%NovemberDecember2024FebruaryMarchApril
-97.62%
-4.42%
AFMD (Affimed N.V.)
Benchmark (^GSPC)

Worst Drawdowns

The table below displays the maximum drawdowns of the Affimed N.V.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Affimed N.V. was 98.55%, occurring on Oct 27, 2023. The portfolio has not yet recovered.

The current Affimed N.V. drawdown is 97.62%.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-98.55%Jul 20, 20152085Oct 27, 2023
-35.75%Sep 29, 201421Oct 27, 201421Nov 25, 201442
-35.67%Apr 27, 201514May 14, 201515Jun 5, 201529
-33.84%Dec 8, 201432Jan 23, 201536Mar 17, 201568
-29.95%Mar 19, 20157Mar 27, 201519Apr 24, 201526

Volatility

Volatility Chart

The current Affimed N.V. volatility is 25.34%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.


0.00%10.00%20.00%30.00%40.00%NovemberDecember2024FebruaryMarchApril
25.34%
3.35%
AFMD (Affimed N.V.)
Benchmark (^GSPC)

Financials

Financial Performance

The chart below illustrates the trends in the financial health of Affimed N.V. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.

Annual
Quarterly

0.0

Income Statement


Income Statement
Balance Sheet
Cash Flow
Annual
Quarterly

TTM
Revenue

Total Revenue

0.00

Cost Of Revenue

0.00

Gross Profit

0.00
Operating Expenses

Selling, General & Admin Expenses

0.00

R&D Expenses

0.00

Total Operating Expenses

0.00
Income

Income Before Tax

0.00

Operating Income

0.00

EBIT

0.00

Earnings From Continuing Operations

0.00

Net Income

0.00

Income Tax Expense

0.00

Interest Expense

0.00

Other Non-Operating Income (Expenses)

0.00

Extraordinary Items

0.00

Discontinued Operations

0.00

Effect Of Accounting Charges

0.00

Non Recurring

0.00

Minority Interest

0.00

Other Items

0.00
Values in undefined except per share items